We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Tofacitinib for Sjögren syndrome with renal tubular acidosis and psoriasis.
- Authors
Li, Man; Liao, Pin‐Hsu; Xiang‐Zhang, Gui; Xin‐Xie, Yong; James, Wei Cheng‐Chung
- Abstract
This article discusses a rare case of a patient with Sjögren syndrome (SS) and psoriasis who was successfully treated with the Janus kinase inhibitor, tofacitinib. The patient presented with symptoms such as xerostomia, xerophthalmia, blurred vision, itching skin rash, scaly plaques, muscle weakness, and weight loss. Laboratory results showed abnormalities in potassium levels, CO2 combining power, blood urea nitrogen, creatinine, and inflammatory markers. Treatment with tofacitinib, along with other medications, resulted in significant improvement in symptoms and laboratory values without any adverse events. The article highlights the potential of targeted synthetic drugs like tofacitinib in the treatment of autoimmune diseases.
- Subjects
SJOGREN'S syndrome; RENAL tubular transport disorders; PSORIASIS; ARRHYTHMIA; JAK-STAT pathway; ACIDOSIS
- Publication
International Journal of Rheumatic Diseases, 2024, Vol 27, Issue 1, p1
- ISSN
1756-1841
- Publication type
Article
- DOI
10.1111/1756-185X.14872